Cure Alliance scientists, after two years of fighting COVID-19, return to their original missions
The Cure Alliance is a boutique 501(c)(3) non-profit group of top scientists, researchers, medical doctors and innovators, plus those who support our efforts to end human suffering by developing cures for chronic, debilitating and fatal diseases.
Our #1 goal has always been to help accelerate potential cures from the laboratory to the patient’s bedside.
Today, with great urgency, our priority is to tear down the remaining barriers to curing diseases and advance well-designed, clinical trials with achievable goals.
We are also expanding our resources into the exciting emerging science of healthspan, living longer without disease.
We continue to join forces with teams around the world, sharing knowledge, advancing cures, contributing to science to help end human suffering.
silence pancreatic cancer with Scruffy
Scruffy
our loyal pandemic pooches and the good, the bad and the crazy haircuts we gave them
After our Scruffy “ambassadors” raised money for life-saving lung treatments for the most severe COVID-19 cases, they have embraced a new mission, enlisting in The Cure Alliance’s new fundraising priority to silence the deadliest form of pancreatic cancer with a single-digit survival rate. SCRUFFY is the best-selling unique photo/art book documenting a dog’s life during the 2020 Pandemic, a metaphor for our courage, resiliency and hope.
Now, 100% of the proceeds from this book will go directly to FDA-authorized phase II clinical trial using 3 non-toxic low-cost generic oral drugs that, when combined, silence stage 4 adenocarcinoma pancreatic cancer. The Cure is Now. The trial will be expanded to test the drug combination on glioblastoma, colorectal, prostate and triple-negative breast cancers, all which share the same cancer mechanism.
Just click below.
Ricordi’s UC-MSC COVID19 Trial Gets $3M Infusion
FOR IMMEDIATE RELEASE: Miami, Fla. (May 6, 2020) – The Diabetes Research Institute Foundation (DRIF) today announced a donation of $3 million from North America’s Building Trades Unions (NABTU), to support the clinical trial of umbilical cord mesenchymal stem cells...
Planning Begins For Phase II Trial Of UC-MSC For Most Severe COVID-19 Cases
FOR IMMEDIATE RELEASE May 5, 2020: The Cure Alliance announces the start of planning for phase II of the clinical trial of umbilical cord-derived mesenchymal stem cells (UC-MSCs) to block the life-threatening lung inflammation that accompanies severe cases of...
Watch MSNBC: Major Med Centers join Cure Alliance in UC MSC Therapy
Continuing his rounds on TV, our Dr. Camillo Ricordi appeared on MSNBC's Kasie DC Sunday. Watch his one-on-one interview above. Video: MSNBC